Department of Biochemistry, University of Geneva, Geneva 4, Switzerland.
The University of Queensland, Institute for Molecular Bioscience and Center for Microscopy and Microanalysis, Brisbane 4072, Australia.
Biol Cell. 2013 May;105(5):219-233. doi: 10.1111/boc.201200036. Epub 2013 Apr 17.
In animals, adipose tissue contains the main energy store as lipid droplets (LDs) composed of esterified cholesterol (CE) and triacylglycerol (TAG) enveloped in a mono-layer of phospholipid and decorated by a coat of proteins. Upon increased energy demand, dedicated lipases hydrolyse TAG stepwise into free fatty acids that are released in circulation and made available to peripheral tissue. In case of aberrant caloric load, TAGs are deposited into non-adipocyte tissues, primarily liver cells. For instance, non-alcoholic fatty liver disease (NAFLD) is a common chronic disorder characterised by an excess of TAG in the liver of patients regardless of their susceptibility to obesity, diabetes or exposure to alcohol. Several independent linkage studies have associated NAFLD with a non-synonymous variant of patatin-like phospholipase domain-containing 3 (PNPLA3/adiponutrin) encoding an isoleucine to methionine substitution at position 148 (I148M) (see Cohen et al., 2011 for review). However, the mechanism by which a variation in PNPLA3 gives susceptibility to NAFLD is not known, primarily because the physiological role of PNPLA3 still needs to be elucidated.
We have identified PNPLA3 in a screen for genes upregulated by intracellular lipid accumulation. We investigated the sub-cellular distribution and potential function of PNPLA3 in fibroblast-like cells supplemented with lipids. We demonstrate that PNPLA3 is targetted to LDs in a process that requires an intact Brummer box domain, which is conserved in the patatin-like phospholipase family. We show that increased levels of the NAFLD-linked PNPLA3 isoform leads to larger LDs, whereas decreased levels of PNPLA3 had the opposite effect. Interestingly, however, PNPLA3 induced a reduction in LD size upon co-expression with ABDH5/CGI-58, an activator of the TAG lipase PNPLA2, which is the closest homolog of PNPLA3. By investigating LD populations according to their size and composition, we show that perturbing intracellular lipid trafficking drastically modifies LD nature.
Taken together, our results suggest that PNPLA3 exhibits a dual function in LD metabolism, and that it participates in the restoration of lipid homeostasis upon aberrant intracellular lipid accumulation.
在动物体内,脂肪组织是主要的能量储存库,其中包含由酯化胆固醇(CE)和三酰基甘油(TAG)组成的脂滴(LDs),这些物质被单层磷脂包裹,并由一层蛋白质装饰。当能量需求增加时,专门的脂肪酶会逐步水解 TAG,生成游离脂肪酸,这些脂肪酸会在循环中释放出来,并可供外周组织使用。在热量摄入异常的情况下,TAG 会被沉积到非脂肪细胞组织中,主要是肝细胞。例如,非酒精性脂肪性肝病(NAFLD)是一种常见的慢性疾病,其特征是患者肝脏中的 TAG 含量过多,而不论其是否容易肥胖、患有糖尿病或接触酒精。几项独立的连锁研究将 NAFLD 与 patatin-like 磷脂酶结构域包含 3(PNPLA3/脂联素)的非同义变体相关联,该变体在 148 位(I148M)有一个由异亮氨酸到蛋氨酸的取代(参见 Cohen 等人,2011 年综述)。然而,PNPLA3 变异导致 NAFLD 的机制尚不清楚,主要是因为 PNPLA3 的生理作用仍需阐明。
我们在筛选受细胞内脂质积累上调的基因时发现了 PNPLA3。我们研究了补充脂质的成纤维样细胞中 PNPLA3 的亚细胞分布和潜在功能。我们证明,PNPLA3 在一个需要完整 Brummer 盒结构域的过程中被靶向到 LD,该结构域在 patatin-like 磷脂酶家族中保守。我们表明,NAFLD 相关的 PNPLA3 同工型的水平增加会导致 LD 增大,而 PNPLA3 水平降低则会产生相反的效果。有趣的是,然而,当与 ABHD5/CGI-58 共表达时,PNPLA3 会诱导 LD 变小,ABHD5/CGI-58 是 PNPLA2 的 TAG 脂肪酶的激活剂,是 PNPLA3 最接近的同源物。通过根据 LD 的大小和组成对其进行分类,我们表明干扰细胞内脂质运输会极大地改变 LD 的性质。
综上所述,我们的结果表明,PNPLA3 在 LD 代谢中表现出双重功能,并且它参与了异常细胞内脂质积累后的脂质稳态恢复。